High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
The prevalence of drug resistance was determined among 64 HIV-infected Thai patients who were failed while receiving nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens. Eighty-nine percent of patients had 1 or more NNRTI mutation resistances. Almost all patients had resistance to a...
Saved in:
Main Authors: | Ploenchan Chetchotisakd, Siriluck Anunnatsiri, Sasisopin Kiertiburanakul, Ruengpung Sutthent, Thanomsak Anekthananon, Chureeratana Bowonwatanuwong, Boonchai Kowadisaiburana, Khuanchai Supparatpinyo, Manassinee Horsakulthai, Sanchai Chasombat, Kiat Ruxrungtham |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=35448999929&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61708 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
by: Ploenchan Chetchotisakd, et al.
Published: (2018) -
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
by: P. Chetchotisakd, et al.
Published: (2018) -
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
by: P. Chetchotisakd, et al.
Published: (2018) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018)